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Abstract. Chemotherapy-based eradication programs are aimed at stopping transmission ofWuchereria bancrofti
by its obligatory mosquito vector. This study compares one year post-treatmentW. bancrofti infection rates ofAnoph-
eles punctulatus, the main vector of lymphatic filariasis in Papua New Guinea, using traditional dissection techniques
and a polymerase chain reaction (PCR)-based ELISA of a parasite-specificSsp I repeat. A total of 633 mosquitoes
in 35 batches were dissected. Six batches containedW. bancrofti-infected mosquitoes, giving a minimum infection
rate of 0.9%. This value was not different than the actual infection rate, which was 9 (1.4%) of 633 mosquitoes (P
 0.48). The DNA was extracted from 47 pools containing a mean of 13.2 mosquitoes per pool. A total of 621
mosquitoes were processed for the PCR-ELISA, including 486 caught by human bait and 135 by light trap, which
included both dead and live mosquitoes. Of 23 pools of alcohol-preserved human-bait mosquitoes, seven were positive
by the PCR-ELISA, giving an infection rate identical to that obtained by dissection of individual mosquitoes (1.4%).
The minimum infection rates for pools of light-trap mosquitoes found dead and alive were 2.7% (2 of 74) and 4.9%
(3 of 61), respectively. These values did not differ from each other (P  0.84), but the overall infection rate of light-
trap mosquitoes was greater than that of mosquitoes captured by human bait (3.7% versus 1.4%;P  0.09). These
data indicate that the PCR-ELISA of aW. bancrofti Ssp I repeat using pools of mosquitoes is comparable to traditional
dissection techniques for monitoring transmission intensity following introduction of mass chemotherapy. This ap-
proach may also be useful for rapid and cost-effective assessment of transmission in endemic areas where the fre-
quency of overt lymphatic pathology is low.
INTRODUCTION
Lymphatic filariasis continues to be a major source of
morbidity and permanent disability in endemic populations,
with more than 128 million people estimated to be infected
currently.1 Recent clinical trials have shown that two-drug
treatment with diethylcarbamazine (DEC) in combination
with ivermectin or albendazole is significantly more effec-
tive than treatment with a single drug alone, yielding up to
99% clearance in microfilaremia up to one year after treat-
ment.2,3 These findings raised the possibility that a two-drug
treatment regimen might effectively interrupt transmission of
Wuchereria bancrofti, and were primarily responsible for the
resolution by the World Health Assembly to eliminate lym-
phatic filariasis as a public health problem.4
An elimination strategy based on once-yearly, two-drug
treatment interventions, has been developed.4 The strategy
is based on the intent to reduce microfilaremia in the com-
munity to levels below which transmission cannot continue.
It is implicit that this reduction be maintained for the dura-
tion of the fecundity of adult worms (4–6 years).
The transmission intensity ofW. bancrofti is measured by
the annual transmission potential, a product of the biting and
infective rates (L3) of mosquito vectors.5,6 Traditionally, de-
tection ofW. bancrofti in mosquitoes requires time-consum-
ing dissection and microscopic examination of individual
mosquitoes. The number of mosquitoes that can be pro-
cessed using this technique is about 35 per person-hour when
dissected fresh. The process is slower if the mosquitoes are
preserved in alcohol. In some endemic areas, mosquitoes
carry more than one species of filarial parasite, and there are
few people with adequate training to distinguish between
different species by microscopy. Accordingly, molecular or
biochemical techniques may be necessary. To monitor the
success of an elimination program and to detect reestablish-
ment of transmission in the post-intervention period, rapid
detection tools that are economical are required. Such tools
must be of sufficient sensitivity and specificity to detect in-
fection rates that can lead to transmission, and of sufficient
simplicity to be applied globally by laboratories with widely
ranging capabilities and resources.
In recent years, it has been shown that the polymerase
chain reaction (PCR) is a sensitive and specific method for
the detection ofW. bancrofti DNA.7–11 Screening of pools of
mosquitoes would also speed up the processing of large
numbers of specimens. A PCR assay for pool screening tar-
geting a repeated DNA segment (Ssp I repeat) in theW.
bancrofti genome has been successfully applied to culicine
mosquitoes includingAedes polynesiensis8 and Culex quin-
quifasciatus.11 However, this technique has not been used to
detect the parasite inAnopheles mosquitoes, which are im-
portant vectors of filariasis in many parts of the world. Fi-
larial larva detection for epidemiologic use must also be
compatible with vector collection and storage methods com-
monly used in endemic areas. Polymerase chain reaction as-
says have thus far been applied to fresh specimens and are
yet to be evaluated for alcohol-preserved or dead mosqui-
toes. The latter constitute a large proportion of light-trap
catches.
We describe the applicability of a standard PCR and a
PCR-based ELISA toAnopheles mosquitoes collected in a
filariasis control area, using the light-trap and human-bait
collection methods. Mosquitoes processed included those
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found dead in light traps and those preserved in 70% etha-
nol. Infection rates determined from pool screening were
compared with those determined by individual dissection.
MATERIALS AND METHODS
Sampling and processing of mosquitoes. Mosquitoes
were caught in Warasikau village where once-a-year mass
treatment with DEC in combination with ivermectin started
in June 1997. Warasikau is located in the Dreikikir District
of East Sepik Province of Papua New Guinea, previously
described by Bockarie and others.12 Lymphatic filariasis
caused by W. bancrofti is highly endemic in the Dreikikir
area where Anopheles punctulatus complex mosquitoes are
the only known vectors.13,14 Mosquitoes used in this study
were collected during March 1998, nine months after first
mass treatment. Collections were performed using the Cen-
ters for Disease Control and Prevention (CDC) (Atlanta,
GA) light trap and the human-bait catch methods as de-
scribed previously.13 Night-landing catches were conducted
outdoors between 6:00 PM and 6:00 AM. The CDC light-traps
were operated inside houses between 6:00 PM and 6:00 AM.
Collections were performed for eight consecutive nights.
Mosquitoes collected by the night-landing method were pre-
served in 70% ethanol. Those caught in light traps were
separated into dead and alive and stored in liquid nitrogen.
Mosquitoes caught in light traps during the eight nights
were processed by PCR. Human-bait catches from nights 1–
4 were individually dissected in batches of 20 to determine
parasite infection and infective rates. Alcohol-preserved
mosquitoes were stained with hemalum and dissected in
glycerol as described previously.13 Light-trap mosquitoes
collected during nights 5–8 were processed by the PCR-
based assay for comparison with results from the previous
four nights. Ethical approval for this study and the procedure
for oral informed consent were obtained from the Medical
Research and Advisory Council of Papua New Guinea and
Case Western Reserve University/University Hospitals of
Cleveland Human Investigation Committee.
Extraction of DNA and PCR amplification. The DNA
was extracted from mosquitoes according to the method de-
scribed by Chanteau and others.15 The PCR amplification of
the W. bancrofti Ssp I repeat was performed as described by
Williams and others9 with modifications introduced to facil-
itate a quantitative ELISA-based aspect. Each amplification
reaction was performed in a final volume of 50 l containing
two oligonucleotide primers, NV-1, NV-2, and 100 fg of an
internal plasmid-based control.16 The sequences of these
primers were NV-1: 5-CGTGATGGCATCAAAGTAGCG-
3 (21-mer) and NV-2: 5-CCCTCACTTACCATAAGA-
CAAC-3 (22-mer). The NV-2 primer (reverse) used was
biotinylated at the 5 end to obtain a PCR product that can
bind to a streptavidin-coated microtiter plate. The PCR con-
ditions were the same as described previously.9 The PCR
products (8 l) were subjected to electrophoresis on a 1.5%
agarose gel and visualized by staining with ethidium bro-
mide to confirm amplification before the ELISA.
The PCR-ELISA. This procedure was performed accord-
ing to the detailed protocol developed by Fischer and oth-
ers.16 Microtiter plates (Lab-Systems, Needham Heights,
MA) were coated overnight at 4C using 1 g/ml of strep-
tavidin (Sigma, St. Louis, MO) in coating buffer (0.1 M
Na2C03-NaHCO3, pH 9.6). For duplicate testing of each sam-
ple (once with control hybridization probe and once with the
wild-type Ssp I-specific hybridization probe), 40 l of the
biotinylated PCR product from each pool was mixed with
360 l of hybridization buffer (6 SSPE [0.8 M sodium
phosphate, pH 8.3, 5 mM EDTA]), 5 Denhardt’s solution
(0.01% ficoll, 0.01% polyvinylpyrrolidone, 0.01% bovine
serum albumin), 0.1% sodium sarcosine, 0.02% sodium do-
decyl sulfate, 0.05% NaN3). 100 l of the solution was then
added to each of four wells. Samples were left to incubate
for 30 min at room temperature before adding 100 l of 0.3
M NaOH to denature the DNA. The wells were subsequently
washed once with 1 phosphate-buffered saline (PBS) and
hybridization buffer.
For each sample, two of the wells were hybridized with
the wild-type Ssp I-specific DNA probe and two were hy-
bridized with the internal-control–specific DNA probe. Fol-
lowing hybridization for 30 min at 55C, the wells were
washed twice with 1 PBS and once with 1 PBS/0.1%
bovine serum albumin (BSA) for 5 min at 55C. Thereafter,
anti-fluorescein alkaline phosphate Fab fragment (Boehrin-
ger Mannheim, Mannheim, Germany) was diluted 1:3,000
in 1 PBS/0.1% BSA and 100 l was added to each well.
After incubation for 30 min at 37C, the wells were washed
three times with 1 PBS/0.5% Tween 20 and two times with
1% diethanolamine/20 mM MgCl2 (pH 10.0). Finally, 100
l of alkaline phosphate substrate was added according to
the instructions of the manufacturer (AP substrate Tablets
104: Sigma). Typical color development started immediately
after addition of the substrate. The ELISA reading was made
at 405 nm following a 1-hr incubation at 37C using a Vmax
microplate reader (Molecular Devices, Sunnyvale, CA). A
positive reading was defined as five times the optical density
of the negative controls (PCR product from 100 fg of the
internal control plasmid DNA and water instead of mosquito
genomic DNA).
To compare the sensitivity of the PCR-ELISA with a stan-
dard PCR assay, all samples were retested using conditions
similar to those described above except that the internal con-
trol was omitted. The PCR products (8 l) were subjected
to electrophoresis on a 1.5% agarose gel, stained with SYBR
Gold (Molecular Probes, Eugene, OR), and visualized with
a STORM 860 optical scanner (Molecular Dynamics, Sun-
nyvale, CA).
RESULTS
Dissections. Table 1 shows the infection rates of mosqui-
toes determined by dissection. A total of 633 An. punctulatus
mosquitoes were dissected in 35 batches, 28 of which con-
tained 20 mosquitoes. The other 7 batches contained 7–10
mosquitoes. Infected mosquitoes were detected in 6 batches.
Four of the infected batches contained only one infected
mosquito; the other two had two and three, bringing the total
number of infected mosquitoes to nine. The infection rate
based on one infected mosquito per batch (0.9%) was lower
than the true infection rate (1.4%) but the difference was not
statistically different (2  0.49, degrees of freedom [df] 
1, P  0.484). None of the mosquitoes contained L3.
The PCR-ELISA. The DNA was extracted from 47 pools
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* Assuming one infected mosquito per pool.
FIGURE 1. Detection of Wuchereria bancrofti by a polymerase chain reaction (PCR) from 23 pools of Anopheles punctulatus. The PCR
products were subjected to electrophoresis on a 1.5% agarose gel, stained with SYBR Gold (Molecular Probes, Eugene, OR), and visualized
by scanning with a STORM 860 optical scanner (Molecular Dynamics, Sunnyvale, CA). Lane 1, a 100-basepair (bp) ladder (molecular size
marker), lanes 6 and 8, positive pools; lane 14, positive control; lane 26, negative control.
of 1–28 mosquitoes (mean  13.2). A total of 621 mosqui-
toes were processed, including 486 caught by human bait
and 135 by light trap. The human-bait mosquitoes were all
caught alive and anesthetized by exposure to chloroform be-
fore preservation in 70% ethanol. The light-trap mosquitoes
included 74 (54.8%) that were already dead before they were
preserved. All PCR products tested by the ELISA contained
a 188 basepair (bp) internal control product. Visualization
of amplified control products by gel electrophoresis con-
firmed a successful PCR from each of the 47 pools. Table 1
shows the infection status of pools of mosquitoes processed
by the PCR-ELISA. Of 23 pools of alcohol-preserved hu-
man-bait mosquitoes, only seven were positive, giving a
minimum infection rate of 1.4%. Dead and living mosqui-
toes found in light traps were placed in different pools. Of
a total of 13 pools of dead light-trap mosquitoes, two were
ELISA positive compared with three of 11 pools of live
mosquitoes. The minimum infection rates for these two
light-trap groups were 2.7% (2 of 74), and 4.9% (3 of 61),
respectively (Yates’ corrected 2  0.04, df  1, P  0.844).
The overall minimum infection rate for light-trap mosquitoes
(3.7%) was greater than human-bait mosquitoes (1.4%), but
the difference was not statistically significant (2  3.52, df
 1, P  0.06).
Standard PCR. The reaction mixtures for the standard
PCR assay did not contain the internal control used in the
PCR-ELISA. Thus, the 188-bp product could only be visu-
alized in the positive control and in pools containing W.
bancrofti genomic DNA. Figure 1 shows the fluorescence
scanned image of PCR products from 25 reaction mixtures,
including two positive pools (lanes 6 and 8), a positive con-
trol (lane 14), and a negative control (lane 26). The 188-bp
product indicating the presence of W. bancrofti was ob-
served in 8 of the 47 pools processed. All pools positive by
the standard PCR were also positive by the PCR-ELISA but
four ELISA-positive products were negative by the standard
PCR. There was no significant difference in the minimum
infection rate determined for all 621 specimens by PCR-
ELISA (1.8%) and standard PCR (1.2%) (P  0.05).
DISCUSSION
As global programs aimed at eradication of Bancroftian
filariasis are implemented, it will become increasingly im-
portant to evaluate their effectiveness in a timely and cost-
effective manner. Evaluation of transmission potential of the
local mosquito population represents an approach that is
minimally intrusive to residents of endemic areas. In addi-
tion, because of the relatively long period of time between
exposure and establishment of infection (months) or devel-
opment of lymphatic disease (years) in humans, monitoring
of mosquito infection rates is likely to detect changes in
transmission in a more timely fashion. In this study, we used
a specific, inexpensive PCR-based ELISA to detect W. ban-
crofti infection in pools of An. punctulatus in an area where
mass chemotherapy with DEC plus ivermectin had been dis-
tributed one year earlier. The low post-treatment infection
rate determined by traditional methods using individually
dissected mosquitoes (1.4%) suggests that large numbers of
mosquitoes will need to be evaluated to detect statistically
significant changes brought about by further chemotherapy.
Studies of L3 infection rates in Tanzania estimate that more
than 40,000 mosquitoes need to be evaluated to detect
changes in transmission intensity effected by more than one
annual treatment with DEC.17 Individual dissections of such
large numbers of mosquitoes are not economically feasible
in some endemic countries such as Papua New Guinea where
labor costs are relatively high. When we carried out this
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study, the cost of employing one trained technician to dissect
this many mosquitoes was estimated to be US $3,000. In
contrast, it is estimated that the cost of reagents and tech-
nician time for the PCR-ELISA described here is $1,880.
The costs of thermocyclers have been going down and are
now comparable to stereomicroscopes.
The data presented here show that PCR-ELISA detection
of a W. bancrofti-specific Ssp I repeat using pools of human-
bait- or light-trap-captured mosquitoes was similar to tradi-
tional dissection approaches in terms of its ability to detect
minimal infection rates. These results are encouraging in
terms of the potential precision and sensitivity of pool
screening given the fact that more than one infected mos-
quito may be contained in pools of variable numbers. The
higher proportion of infected mosquitoes detected in batches
captured using light traps compared with human bait may in
part be explained by the presence of infected blood meals
in fresh mosquitoes caught by the former method. If human-
bait catches are performed properly, they should not include
blood-fed mosquitoes.
Anopheles mosquitoes are important vectors of W. ban-
crofti in Africa, Asia, and some areas of the Pacific. How-
ever, PCR-based techniques to detect infection have not been
previously evaluated for these vectors. In addition, despite
the fact that 70% ethanol is a widely used preservative for
mosquitoes collected during the course of filariasis surveys,
there are no reports of how ethanol affects the utility of
PCR-based approaches. Previous studies of these assays
have been limited to fresh or frozen culicine mosquitoes.8,11
The results presented here indicate that ethanol-preserved
Anopheles mosquitoes are suitable for use in PCR-based as-
says. In addition, results showing that the PCR method de-
tects infection in dead mosquitoes collected in light traps
suggest that these specimens may be suitable for pool
screening. Filarial larvae rapidly degenerate in dead mos-
quitoes left at room temperature for more than 1 hr. In the
present study, 54.8% of the mosquitoes collected from light
traps were dead and dehydrated.
To evaluate the relative sensitivity of a standard PCR as-
say with gel electrophoresis and the PCR-ELISA, results ob-
tained with the two approaches were compared. Despite us-
ing highly sensitive gel staining and imaging techniques to
visualize the 188-bp product, four pools of mosquitoes that
were positive by PCR-ELISA were negative by standard
PCR. These results suggest that the PCR-ELISA may be
more sensitive for detection of the W. bancrofti Ssp I repeat.
This difference may be related to potent PCR inhibitors in
mosquitoes.18 The PCR-ELISA used here was designed to
circumvent this problem (i.e., ascertain false-negative reac-
tions) by using an internal control DNA template that is co-
amplified with the target W. bancrofti sequence. The use of
such an internal control in studies carried out by Fischer and
others16 demonstrated that the PCR-ELISA is 10-fold more
sensitive than conventional electrophoresis when applied to
known quantities of internal control template, as was done
in the current study.
The utility of the PCR-ELISA and other DNA detection
methods relative to other approaches for rapid and cost-ef-
fective determination of levels of filarial endemicity and the
need for control measures remain to be established. Giapong
and others19 have reported that evaluation of the prevalence
of lymphatic disease (hydrocele and/or lymphatic pathology
of the extremities) may be useful for rapid assessment in
these circumstances. Results of studies in which night blood
surveys for microfilaremia, filarial antigenemia, mosquito in-
fection rates, and human disease prevalence are directly
compared should be helpful in deciding which strategies are
most informative as well as cost-effective.
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